Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

About Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder that causes accumulation of sphingomyelin in various organs. In addition to a low incidence, ASMD has a heterogeneous presentation that makes management challenging. Join experts Margaret McGovern, MD, PhD, and Pramod Mistry, MD, PhD, in this review of the diagnosis and treatment of patients with ASMD.

Publisher

Annenberg Center for Health Sciences

Category

health & fitness

Language

en

Explicit

No

First episode

26 May 2022

Latest episode

26 May 2022

Latest episodes

5 episodes in the feed.

1. 

   26 May 2022

   Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

   Overview of olipudase alfa Efficacy and safety of olipudase alfa from phase 2 and 3 trials

2. 

   26 May 2022

   Clinical Management and Treatment Monitoring Part 2

   Surveillance recommendations for patients with ASMD Ongoing symptomatic management and support Role of liver transplantation

3. 

   26 May 2022

   Clinical Management and Treatment Monitoring Part 1

   Initial evaluation and management of ASMD Clinical trial enrollment

4. 

   26 May 2022

   Guidelines for the Diagnosis of ASMD

   Clinical presentations of ASMD Diagnostic algorithms Enzymatic testing

5. 

   26 May 2022

   Defining ASMD

   Pathophysiology of ASMD ASMD phenotypes

Contact Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.